{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:03:53Z","timestamp":1777525433636,"version":"3.51.4"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["ALFGBG 1006219"],"award-info":[{"award-number":["ALFGBG 1006219"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pharmacosmos A\/S"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,2,25]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron deficiency (ID) is common in patients with heart failure (HF). Current guidelines define ID based on serum ferritin and transferrin saturation (TSAT) rather than soluble transferrin receptor (STFR) or ratios such as iron\/STFR or TSAT\/STFR. We investigated the associations between these biomarkers and prognosis in patients with new-onset HF with reduced ejection fraction (HFrEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients hospitalised in 2016\u20132020 at Sahlgrenska University Hospital with new-onset HFrEF who had iron biomarkers measured within 6 months of discharge were included, with follow-up from the date of the iron biomarker test until 31 December 2021. The primary composite event of interest was first re-hospitalisation for HF (HHF) or all-cause mortality. The associations between ID biomarkers and endpoints were analysed using Cox regression adjusted for age, sex, previous HF, left ventricular ejection fraction, HF medications and comorbidity. Bonferroni-Holm correction was applied for multiple testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 325 patients included (median age 68 (57\u201376) years, 70.2% men), 168 (52%) had ID using current guideline criteria and STFR was available for 224 (69%) patients. Median follow-up was 2.2 years. In the prespecified analysis plan, biomarkers of ID were not statistically significantly associated with the primary composite endpoint, although each SD increase in TSAT was associated with 56% lower risk of HHF (0.44 [0.27\u20130.71]) as were increased ratios of iron\/STFR (0.58 [0.40\u20130.86]) and TSAT\/STFR (0.55 [0.37\u20130.83]). However, in a post hoc sensitivity analysis in which patients with extreme values were excluded, each increase in SD of TSAT was associated with 47% lower risk of the primary composite endpoint (0.53 [0.35\u20130.79]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lower TSAT is associated with a greater risk of clinical events in patients with new-onset HF, as were the ratios of iron\/STFR and TSAT\/STFR. However, neither ratio appeared to offer a substantial advantage compared with TSAT alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2025-003898","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:40:18Z","timestamp":1773934818000},"page":"e003898","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers of iron deficiency and prognosis in patients hospitalised with new-onset heart failure and a reduced left ventricular ejection fraction"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-7524","authenticated-orcid":false,"given":"Jonathan S M","family":"Johansson","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefin","family":"Henrysson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Internal Medicine, Geriatrics and Emergency Care, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Basic","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Internal Medicine, Geriatrics and Emergency Care, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7016","authenticated-orcid":false,"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[{"name":"University of Glasgow School of Cardiovascular & Metabolic Health, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Internal Medicine, Geriatrics and Emergency Care, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotta","family":"Ljungman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026031908401150000_13.1.e003898.1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.139"},{"key":"2026031908401150000_13.1.e003898.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.039"},{"key":"2026031908401150000_13.1.e003898.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2026031908401150000_13.1.e003898.4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026031908401150000_13.1.e003898.5","doi-asserted-by":"crossref","first-page":"102662","DOI":"10.1016\/j.jchf.2025.102662","article-title":"Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific Outcomes","volume":"13","author":"Lindberg","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026031908401150000_13.1.e003898.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"2026031908401150000_13.1.e003898.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"2026031908401150000_13.1.e003898.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03671-1"},{"key":"2026031908401150000_13.1.e003898.9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026031908401150000_13.1.e003898.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae086"},{"key":"2026031908401150000_13.1.e003898.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad586"},{"key":"2026031908401150000_13.1.e003898.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3833"},{"key":"2026031908401150000_13.1.e003898.13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2014.10.006","article-title":"Bone marrow iron depletion is common in patients with coronary artery disease","volume":"182","author":"Jankowska","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026031908401150000_13.1.e003898.14","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2011.557086"},{"key":"2026031908401150000_13.1.e003898.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32339-4"},{"key":"2026031908401150000_13.1.e003898.16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-322145"},{"key":"2026031908401150000_13.1.e003898.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu235"},{"key":"2026031908401150000_13.1.e003898.18","doi-asserted-by":"crossref","first-page":"133133","DOI":"10.1016\/j.ijcard.2025.133133","article-title":"Association of elevated levels of soluble transferrin receptor with left ventricular remodeling and mortality in patients with heart failure: Evidence from observational and genetic investigations","volume":"428","author":"Gao","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026031908401150000_13.1.e003898.19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13164742","article-title":"Prognostic Role of Tissue Iron Deficiency Measured by sTfR Levels in Heart Failure Patients without Systemic Iron Deficiency or Anemia","volume":"13","author":"Ramos-Polo","year":"2024","journal-title":"J Clin Med"},{"key":"2026031908401150000_13.1.e003898.20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2036"},{"key":"2026031908401150000_13.1.e003898.21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cardfail.2021.12.018","article-title":"Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study","volume":"28","author":"Fitzsimons","year":"2022","journal-title":"J Card Fail"},{"key":"2026031908401150000_13.1.e003898.22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011728","article-title":"Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations","volume":"18","author":"Gan","year":"2025","journal-title":"Circ Heart Fail"},{"key":"2026031908401150000_13.1.e003898.23","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3295"},{"key":"2026031908401150000_13.1.e003898.24","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2879"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2025-003898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:40:19Z","timestamp":1773934819000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2025-003898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/openhrt-2025-003898"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2025-003898","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}